This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Spiber Inc., Crane Limited, Riken Corporation. Active years: 2023-2026.
Company Filing History:
2 out of 34 
1 out of 7 
1 out of 888 
Years Active: 2023-2026
Title: Koichi Kotaka: Innovator in Modified Fibroin
Introduction
Koichi Kotaka is a notable inventor based in Tsuruoka, Japan. He has made significant contributions to the field of biotechnology, particularly through his innovative work on modified fibroin. His research has implications for various applications, including materials science and bioengineering.
Latest Patents
Koichi Kotaka holds a patent for a modified fibroin. This invention relates to a modified fibroin that includes a domain sequence represented by Formula 1: [(A)motif-REP] or Formula 2: [(A)motif-REP]−(A)motif. The domain sequence has an amino acid sequence with a reduced content of a glutamine residue, which is achieved by deleting or substituting one or more glutamine residues in REP with other amino acid residues, compared to naturally occurring fibroin. This innovation is a testament to his expertise and creativity in the field.
Career Highlights
Throughout his career, Koichi Kotaka has worked with prominent companies such as Spiber Inc. and Riken Corporation. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in biotechnology.
Collaborations
Koichi has collaborated with notable coworkers, including Keisuke Morita and Yunosuke Abe. These partnerships have further enriched his research and development efforts, leading to advancements in the field.
Conclusion
Koichi Kotaka is a distinguished inventor whose work on modified fibroin showcases his innovative spirit and dedication to advancing biotechnology. His contributions continue to influence the industry and inspire future research.